NEW DELHI, April 11, 2017: CORE Diagnostics is partnering with Silicon Valley-based CellMax Life to immediately introduce CellMax Life’s genetic cancer risk test and ctDNA-based liquid biopsy throughout India. The two diagnostic advancements hold immense promise to reduce India’s cancer mortality by offering personalized, precision cancer risk assessment and screening.
![logo](https://corediagnostics.in/wp-content/uploads/2022/11/Logo_CORE_White-uai-258x99-1-1.png)